Mississippi lawmakers are considering House Bill 602 and Senate Bill 2014, both designed to ensure consumers know whether ...

Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.

The Supreme Court will hear oral arguments on Tuesday in a clash over whether a North Carolina-based company can challenge the Food and Drug Administration’s denial of its application to market ...

No. 4 Alabama enters a matchup against No. 14 Mississippi State as winners of five consecutive road games. The teams match up Wednesday for the first time this season.

Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

There were unforgiveable shortcomings in management, which included critical information not reaching senior officials as ...

The Food & Drug Administration (FDA), has quietly taken down their guidance detailing diversity action plans for clinical ...

At oral arguments earlier this week the Supreme Court was skeptical of the Food and Drug Administration’s effort to block a North Carolina-based company from challenging the denial of its application ...

The FDA has added a boxed warning, its most serious designation, to Copaxone and Glatopa due to the risk of anaphylaxis, a rare but serious allergic reaction. This severe reaction can occur at any ...

The FDA said the biosimilar, called Tyruko, has been approved to treat adults with relapsing forms of MS and active secondary progressive MS, as well as for certain patients with Crohn's disease ...